clioquinol has been researched along with Hormone-Dependent Neoplasms in 1 studies
Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, D | 1 |
Cui, QC | 1 |
Yang, H | 1 |
Barrea, RA | 1 |
Sarkar, FH | 1 |
Sheng, S | 1 |
Yan, B | 1 |
Reddy, GP | 1 |
Dou, QP | 1 |
1 other study available for clioquinol and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
Topics: Androgen Receptor Antagonists; Animals; Apoptosis; Cell Line, Tumor; Clioquinol; Copper; Humans; Mal | 2007 |